To further determine the effects of GBM therapy (TMZ & RT) on BIRC3 expression, we examined human GBM cells that were rendered resistant to TMZ through step-wise exposures with two fold increases in TMZ concentration as well as GBM cell lines exposed to RT (see Materials and Methods). This evidence concerns the gene BIRC3 and glioblastoma.